Furthermore, co-treatment with the ConA and Pd(II) complex significantly increased TNF-α and IL-17 ( p < 0.05) concentrations, while the increase in IL-1β did not reach statistical significance compared to the ConA-simulated group ( Figure 2 B).
1
—
—